drugset / Trial / NCT00393978
Efficacy Study of Quetiapine Plus Topiramate for Reducing Cannabis Consumption and Bipolar Mania
Phase 4
Completed
75 enrolled
University of Cincinnati
National Institute on Drug Abuse (NIDA) · collab
RandomizedFactorialTriple-blindTreatment
Summary
The objectives of this study are to determine whether this treatment may be useful for reducing cannabis consumption; reducing symptoms of bipolar mania; and weight mitigation therapy for individuals on psychopharmacotherapy.
Timeline
- Start
- 2006-11
- Primary completion
- 2011-12
- Completion
- 2014-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Quetiapine | Small molecule | 400 mg | — |
| Comparator | Quetiapine | Small molecule | 800 mg | — |
| Comparator | Topiramate | Small molecule | 150 mg | — |
| Comparator | Topiramate | Small molecule | 300 mg | — |